A COVID-19 diagnosis is no longer as frightening as it used to be, thanks to developments in treatment choices. However, a ...

Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people. A new study, however, suggests that it may now be easier to predict who is ...

Researchers tracking nearly 1,000 individuals with post-COVID-19 syndrome observed minimal changes in their symptoms during ...

Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people.

UPMC saw an increase in RSV cases in its health system, including in Lancaster County, a spokesperson said Jan. 7, especially ...

A simple blood test might determine which patients are at risk for long COVID, a new study says.Higher levels of le ...

Leukocyte count, a widely available and inexpensive clinical marker of inflammation, may help predict the severity of long COVID symptoms in postmenopausal women, researchers reported.

A new study comparing blood samples from menopausal women pre- and post-COVID shows that those with elevated leukocyte (white ...

“Taken together, these results indicate that, once PNP or NNP patients develop neuro-PASC, whether they contracted SARS-CoV-2 infection prior to, or after SARS-CoV-2 vaccination makes little ...

Tamara Dörr, M.D., from the Cantonal Hospital St. Gallen in Switzerland, and colleagues assessed the burden and course of PASC in health care workers during a 30-month period. The analysis included ...

A spike in flu cases in NY offered clues on when the season may end, underscoring it's not too late to get a flu shot.

Women are more likely than men to develop long COVID, a new study finds, with the highest risk in women ages 40 to 54. Women ...